Publication | Open Access

Potential of coronavirus 3C-like protease inhibitors for the development of new anti-SARS-CoV-2 drugs: Insights from structures of protease and inhibitors

MedicineAntiviral Drug DevelopmentNew Anti-sars-cov-2 DrugsAntiviral TherapyVirologyAntiviral DrugViral Structural ProteinPharmacologyAntiviral CompoundBiomolecular EngineeringDrug DiscoveryCovid-19